Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech CompaniesNicole Coustier
Published on: 19/03/2025

A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.

Evidence Planning
Do QALYs Matter in the U.S.?

Do QALYs Matter in the U.S.?

Do QALYs Matter in the U.S.?Nicole Coustier
Published on: 11/03/2025

QALYs are essential in Europe—but not in the U.S. Here's what really drives MedTech coverage decisions and how to pivot.

Payer Coverage
Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms

Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms

Beware Basing Your MedTech Pricing on Short-term New Tech Payment MechanismsNicole Coustier
Published on: 04/03/2025

New tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know.

U.S. Healthcare Fundamentals
How Payer Claims Data Strengthens Medtech Value Stories: Examples from Peer-Reviewed Publications

How Payer Claims Data Strengthens Medtech Value Stories: Examples from Peer-Reviewed Publications

How Payer Claims Data Strengthens Medtech Value Stories: Examples from Peer-Reviewed PublicationsNicole Coustier
Published on: 25/02/2025

Learn how payer claims data strengthens medtech value stories without long clinical trials.

Evidence Planning